| Literature DB >> 26178920 |
Cassandra E Callmann1, Christopher V Barback2, Matthew P Thompson1, David J Hall2, Robert F Mattrey2, Nathan C Gianneschi1.
Abstract
An enzyme-responsive, paclitaxel-loaded nanoparticle is described and assessed in vivo in a human fibrosarcoma murine xenograft. This work represents a proof-of-concept study demonstrating the utility of enzyme-responsive nanoscale drug carriers capable of targeted accumulation and retention in tumor tissue in response to overexpressed endogenous enzymes.Entities:
Keywords: drug delivery; enzyme-responsive; nanomaterials; self-assembly; stimuli-responsive
Mesh:
Substances:
Year: 2015 PMID: 26178920 PMCID: PMC4699560 DOI: 10.1002/adma.201501803
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849